To further evaluate the dynamic changes in tumor proliferation during neoadjuvant endocrine therapy (NET), individual Ki-67 trajectories were analyzed in a subgroup of patients who underwent an on-treatment biopsy. The gene discussed is MKI67; the disease is neoplasm.